| Kolevzon, Alexander |
NCT05187377: A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism |
|
|
| Enrolling by invitation | 2 | 45 | US | Growth Hormone, rhGH, Saline, placebo | Icahn School of Medicine at Mount Sinai, National Institute of Neurological Disorders and Stroke (NINDS) | Phelan-McDermid Syndrome, Autism Spectrum Disorder (ASD) | 03/25 | 03/25 | | |
NCT01970345: A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder |
|
|
| Terminated | 2 | 3 | US | IGF-1, Increlex, mecasermin, Placebo/saline, Saline | Icahn School of Medicine at Mount Sinai, Autism Science Foundation | Autism Spectrum Disorder | 09/17 | 09/17 | | |
| Recruiting | N/A | 24 | US | Ballet for All Kids | Icahn School of Medicine at Mount Sinai, American Psychiatric Association | Autism Spectrum Disorder | 03/25 | 03/25 | | |
NCT02461420: Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome |
|
|
| Active, not recruiting | N/A | 205 | US | | Boston Children's Hospital, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Phelan-McDermid Syndrome Foundation | Phelan-McDermid Syndrome, Autism Spectrum Disorder, Intellectual Disability | 12/25 | 12/26 | | |
NCT03718923: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 50 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder | 04/26 | 04/26 | | |
NCT03718936: ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 30 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | ADNP, Helsmoortel-Van Der Aa Syndrome, Autism Spectrum Disorder | 03/26 | 03/26 | | |
NCT03718910: DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 10 | US | | Icahn School of Medicine at Mount Sinai | DDX3X, Mental Retardation, X-linked 102, Autism Spectrum Disorder | 05/26 | 05/26 | | |
| Rubeis, Silvia De |
NCT03718936: ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 30 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | ADNP, Helsmoortel-Van Der Aa Syndrome, Autism Spectrum Disorder | 03/26 | 03/26 | | |
NCT03718910: DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 10 | US | | Icahn School of Medicine at Mount Sinai | DDX3X, Mental Retardation, X-linked 102, Autism Spectrum Disorder | 05/26 | 05/26 | | |
| Siper, Paige |
NCT03718923: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 50 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder | 04/26 | 04/26 | | |
NCT03718936: ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 30 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | ADNP, Helsmoortel-Van Der Aa Syndrome, Autism Spectrum Disorder | 03/26 | 03/26 | | |
| Drapeau, Elodie |
NCT03718923: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 50 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder | 04/26 | 04/26 | | |
| Lozano, Reymundo |
NCT05358886: A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome |
|
|
| Recruiting | 3 | 150 | US | BPN14770/ zatolmilast, Placebo | Tetra Discovery Partners | Fragile X Syndrome | 06/25 | 09/25 | | |
| Recruiting | 3 | 250 | Europe, US, RoW | ZYN002 - transdermal gel, cannabidiol formulated as a clear gel that can be applied to the skin (transdermal delivery), Placebo, Placebo Comparator, Matching Placebo | Zynerba Pharmaceuticals, Inc., Zynerba Pharmaceuticals, Inc. | Fragile X Syndrome | 05/25 | 05/25 | | |
NCT05163808: A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome |
|
|
| Recruiting | 2/3 | 150 | US | zatolmilast, BPN14770, Placebo | Tetra Discovery Partners | Fragile X Syndrome | 09/25 | 12/25 | | |
NCT03718923: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 50 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder | 04/26 | 04/26 | | |
| Grice, Dorothy |
NCT03718910: DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 10 | US | | Icahn School of Medicine at Mount Sinai | DDX3X, Mental Retardation, X-linked 102, Autism Spectrum Disorder | 05/26 | 05/26 | | |
| Lerman, Bonnie |
NCT03718923: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 50 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder | 04/26 | 04/26 | | |
| Bright, Samantha |
NCT03718923: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 50 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder | 04/26 | 04/26 | | |
NCT03718936: ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 30 | US | | Icahn School of Medicine at Mount Sinai, The Seaver Foundation, Autism Science Foundation, Research Foundation for Mental Hygiene, Inc. | ADNP, Helsmoortel-Van Der Aa Syndrome, Autism Spectrum Disorder | 03/26 | 03/26 | | |
NCT03718910: DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 10 | US | | Icahn School of Medicine at Mount Sinai | DDX3X, Mental Retardation, X-linked 102, Autism Spectrum Disorder | 05/26 | 05/26 | | |
| Silver, Hailey |
NCT03718910: DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. |
|
|
| Recruiting | N/A | 10 | US | | Icahn School of Medicine at Mount Sinai | DDX3X, Mental Retardation, X-linked 102, Autism Spectrum Disorder | 05/26 | 05/26 | | |
